Therefore, we propose that TDG can inhibit the migration and invasion abilities of colon cancer cells by reducing their level of DNMT3A, decreasing the TIMP2 promoter methylation, and increasing the expression of TIMP2. The gene discussed is DNMT3A; the disease is colonic neoplasm.